AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
First molecular evidence for Puumala hantavirus in Slovakia
Authors: Leitmeyer, K Sibold, C Meisel, H Ulrich, R Labuda, M Kruger, DH
Citation: K. Leitmeyer et al., First molecular evidence for Puumala hantavirus in Slovakia, VIRUS GENES, 23(2), 2001, pp. 165-169
Clinical characterization of Dobrava hantavirus infections in Germany
Authors: Schutt, M Gerke, P Meisel, H Ulrich, R Kruger, DH
Citation: M. Schutt et al., Clinical characterization of Dobrava hantavirus infections in Germany, CLIN NEPHR, 55(5), 2001, pp. 371-374
Dobrava hantavirus causes hemorrhagic fever with renal syndrome in centralEurope and is carried by two different Apodemus mice species
Authors: Sibold, C Ulrich, R Labuda, M Lundkvist, A Martens, H Schutt, M Gerke, P Leitmeyer, K Meisel, H Kruger, DH
Citation: C. Sibold et al., Dobrava hantavirus causes hemorrhagic fever with renal syndrome in centralEurope and is carried by two different Apodemus mice species, J MED VIROL, 63(2), 2001, pp. 158-167
Nutraceutical and functional food ingredients for food and pharmaceutical applications
Authors: Meisel, H Bernard, H Fairweather-Tait, S FitzGerald, RJ Hartmann, R Lane, CN McDonagh, D Teucher, B Wal, JM
Citation: H. Meisel et al., Nutraceutical and functional food ingredients for food and pharmaceutical applications, BR J NUTR, 85(5), 2001, pp. 635-635
Bioactive peptides from milk proteins: a perspective for consumers and producers
Authors: Meisel, H
Citation: H. Meisel, Bioactive peptides from milk proteins: a perspective for consumers and producers, AUST J DAIR, 56(2), 2001, pp. 83-92
Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association?
Authors: Genvresse, I Spath-Schwalbe, E Meisel, H Kaufmann, O Kruger, DH Possinger, K
Citation: I. Genvresse et al., Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association?, ANN HEMATOL, 79(9), 2000, pp. 530-532
DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection
Authors: Koletzki, D Schirmbeck, R Lundkvist, A Meisel, H Kruger, DH Ulrich, R
Citation: D. Koletzki et al., DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection, J BIOTECH, 84(1), 2000, pp. 73-78
Natural history of hepatitis C
Authors: Roggendorf, M Meisel, H Viazov, S
Citation: M. Roggendorf et al., Natural history of hepatitis C, MEM I OSW C, 95, 2000, pp. 189-192
Puumala (PUU) hantavirus strain differences and insertion positions in thehepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles
Authors: Koletzki, D Lundkvist, A Sjolander, KB Gelderblom, HR Niedrig, M Meisel, H Kruger, DH Ulrich, R
Citation: D. Koletzki et al., Puumala (PUU) hantavirus strain differences and insertion positions in thehepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles, VIROLOGY, 276(2), 2000, pp. 364-375
Cytochemical assays for the characterization of milk-derived bioactive substances
Authors: Hartmann, R Meisel, H
Citation: R. Hartmann et H. Meisel, Cytochemical assays for the characterization of milk-derived bioactive substances, MILCHWISSEN, 55(12), 2000, pp. 673-675
Manufacturing of alpha-lactalbumin-enriched whey systems by selective thermal treatment in combination with membrane processes
Authors: Kiesner, C Clawin-Radecker, I Meisel, H Buchheim, W
Citation: C. Kiesner et al., Manufacturing of alpha-lactalbumin-enriched whey systems by selective thermal treatment in combination with membrane processes, LAIT, 80(1), 2000, pp. 99-111
Cytochemical model systems for the detection and characterization of potentially bioactive milk components
Authors: Hartmann, R Gunther, S Martin, D Meisel, H Pentzien, AK Schlimme, E Scholz, N
Citation: R. Hartmann et al., Cytochemical model systems for the detection and characterization of potentially bioactive milk components, KIEL MILCHW, 52(1), 2000, pp. 61-85
Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype
Authors: Sobotta, D Sominskaya, I Jansons, J Meisel, H Schmitt, S Heermann, KH Kaluza, G Pumpens, P Gerlich, WH
Citation: D. Sobotta et al., Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype, J GEN VIROL, 81, 2000, pp. 369-378
Interaction of wild-type and naturally occurring deleted variants of hepatitis B virus core polypeptides leads to formation of mosaic particles
Authors: Preikschat, P Kazaks, A Dishlers, A Pumpens, P Kruger, DH Meisel, H
Citation: P. Preikschat et al., Interaction of wild-type and naturally occurring deleted variants of hepatitis B virus core polypeptides leads to formation of mosaic particles, FEBS LETTER, 478(1-2), 2000, pp. 127-132
Post-translational phosphorylation affects the IgE binding capacity of caseins
Authors: Bernard, H Meisel, H Creminon, C Wal, JM
Citation: H. Bernard et al., Post-translational phosphorylation affects the IgE binding capacity of caseins, FEBS LETTER, 467(2-3), 2000, pp. 239-244
Opioid peptides encrypted in intact milk protein sequences
Authors: Meisel, H FitzGerald, RJ
Citation: H. Meisel et Rj. Fitzgerald, Opioid peptides encrypted in intact milk protein sequences, BR J NUTR, 84, 2000, pp. S27-S31
Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme
Authors: FitzGerald, RJ Meisel, H
Citation: Rj. Fitzgerald et H. Meisel, Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme, BR J NUTR, 84, 2000, pp. S33-S37
Nucleosides and nucleotides: natural bioactive substances in milk and colostrum
Authors: Schlimme, E Martin, D Meisel, H
Citation: E. Schlimme et al., Nucleosides and nucleotides: natural bioactive substances in milk and colostrum, BR J NUTR, 84, 2000, pp. S59-S68
HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein
Authors: Koletzki, D Biel, SS Meisel, H Nugel, E Gelderblom, HR Kruger, DH Ulrich, R
Citation: D. Koletzki et al., HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein, BIOL CHEM, 380(3), 1999, pp. 325-333
Hepatitis-B-virus-infection of the mother as a cause of fetal nonimmune hydrops fetalis
Authors: Schroter, B Chaoui, R Meisel, H Bollmann, R
Citation: B. Schroter et al., Hepatitis-B-virus-infection of the mother as a cause of fetal nonimmune hydrops fetalis, Z GEBU NEON, 203(1), 1999, pp. 36-38
Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine
Authors: Meisel, H Preikschat, P Reinke, P Hocher, B Budde, K Bechstein, WO Neuhaus, P Kruger, DH Neumayer, NN
Citation: H. Meisel et al., Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine, TRANSPLAN I, 12(4), 1999, pp. 283-287
Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope
Authors: Lachmann, S Meisel, H Muselmann, C Koletzki, D Gelderblom, HR Borisova, G Kruger, DH Pumpens, P Ulrich, R
Citation: S. Lachmann et al., Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope, INTERVIROLO, 42(1), 1999, pp. 51-56
Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection
Authors: Zibert, A Kraas, W Ross, RS Meisel, H Lechner, S Jung, G Roggendorf, M
Citation: A. Zibert et al., Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection, J HEPATOL, 30(2), 1999, pp. 177-184
New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge
Authors: Ulrich, R Koletzki, D Lachmann, S Lundkvist, A Zankl, A Kazaks, A Kurth, A Gelderblom, HR Borisova, G Meisel, H Kruger, DH
Citation: R. Ulrich et al., New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge, J BIOTECH, 73(2-3), 1999, pp. 141-153
Long-term investigation of hepatitis G virus infection in renal transplantrecipients with and without hepatitis B and C co-infection
Authors: Meisel, H Reip, A Kruger, DH Budde, K Fritsche, L Neumayer, HH
Citation: H. Meisel et al., Long-term investigation of hepatitis G virus infection in renal transplantrecipients with and without hepatitis B and C co-infection, TRANSPLAN P, 31(1-2), 1999, pp. 1382-1383
Risultati: 1-25 | 26-35